Scotia's hopes for magic bullet
The Investment Column
Wednesday 11 September 1996
Yesterday, the group was claiming that its pancreatic cancer drug, codenamed EF13, would soon outshine even Marimastat, the British Biotech anti-cancer treatment that set the sector alight last November. David Horrobin, the driving force behind Scotia, suggested EF13 could be cleared for sale in under two years and might cover a wider range of cancers. But those claims pale beside the qualities attributed to Foscan, its "magic bullet" drug which destroys cancerous cells in association with lasers. Mr Horrobin believes this could be "possibly one of the most exciting drugs, not just for Scotia but for the whole pharmaceutical industry over the next few years".
Even so, the City will remain sceptical about both drugs until more solid phase III trial results emerge and there are question marks aplenty elsewhere. Some seven months after Pharmacia & Upjohn pulled out, the group still has to find a partner to distribute Tarabetic, the diabetic treatment which should be Scotia's first major drug to hit the market early next year.
Meantime, its long-standing businesses selling treatments based on evening primrose oil and lipid technology are struggling, as the 12 per cent dip in first-half turnover shows. Losses deepened by 31 per cent to pounds 7.03m in the six months to June. At the current rate of burn, Scotia's net cash of pounds 39.3m will be used up in about 18 months.
Even after yesterday's 42p fall to 691.5p, the shares, which capitalise Scotia at pounds 532m, look high enough for now.
- 1 Rarest Beanie Baby of them all could be sold for £62,500 on eBay
- 3 Driving while dehydrated can be just as dangerous as drink driving, study suggests
- 4 Farmer told to tear down mock-Tudor castle after hiding construction behind hay bales
- 5 One Direction: Louis Tomlinson launching his own record label, has already 'signed two acts'
Isis video purports to show beheadings and execution at gunpoint of 30 Ethiopian Christians and destruction of churches in Libya
Rarest Beanie Baby of them all could be sold for £62,500 on eBay
Professional big game hunter Ian Gibson crushed to death by elephant during hunt
Driving while dehydrated can be just as dangerous as drink driving, study suggests
Ben Affleck asked TV chiefs to hide slave-owning ancestry, new hacked Sony emails published by Wikileaks claim
If I’m being racially abused I don’t need a stranger with a saviour complex to rescue me
The only black face in the Ukip manifesto is on the page about overseas aid
Ukip is the only main political party to not address LGBT rights in its manifesto
Food banks: One million Britons will soon be using them, according to Trussell Trust
Religion isn't growing, it is becoming vigorous in its demise, says philosopher AC Grayling
BBC election debate: The one photo that summed up the whole 90-minute leaders debate
iJobs Money & Business
£20000 - £25000 per annum + OTE £45,000: SThree: SThree Group have been well e...
£50000 - £667000 per annum + excellent benefits : Ashdown Group: IT Manager / ...
£13000 - £20000 per annum: Recruitment Genius: Scotland's leading life insuran...
£40000 - £45000 per annum + benefits : Ashdown Group: Training Programme Manag...